Listed

Invivyd, Inc.

IVVDNasdaqCIK 1832038HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$14.3m, Q2 FY2026
Operating income−$45.8m, Q2 FY2026
Net income−$44.4m, Q2 FY2026
Invivyd, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure2.3Revenue, Q2 FY2024, three months to 2024-06-30$2.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure9.3Revenue, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure13.8Revenue, Q4 FY2024, three months to 2024-12-31$13.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure11.3Revenue, Q1 FY2025, three months to 2025-03-31$11.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure11.8Revenue, Q2 FY2025, three months to 2025-06-30$11.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure13.1Revenue, Q3 FY2025, three months to 2025-09-30$13.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure17.2Revenue, Q4 FY2025, three months to 2025-12-31$17.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure13.7Revenue, Q1 FY2026, three months to 2026-03-31$13.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure14.3Revenue, Q2 FY2026, three months to 2026-06-30$14.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Research and development$m25.6Research and development, Q3 FY2023, three months to 2023-09-30$25.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure62.3Research and development, Q4 FY2023, three months to 2023-12-31$62.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure31.2Research and development, Q1 FY2024, three months to 2024-03-31$31.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure30.3Research and development, Q2 FY2024, three months to 2024-06-30$30.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure57.9Research and development, Q3 FY2024, three months to 2024-09-30$57.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure17.9Research and development, Q4 FY2024, three months to 2024-12-31$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure10.6Research and development, Q1 FY2025, three months to 2025-03-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure9.6Research and development, Q2 FY2025, three months to 2025-06-30$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure8.0Research and development, Q3 FY2025, three months to 2025-09-30$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure10.0Research and development, Q4 FY2025, three months to 2025-12-31$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure30.7Research and development, Q1 FY2026, three months to 2026-03-31$30.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure29.4Research and development, Q2 FY2026, three months to 2026-06-30$29.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Selling, general and administrative$m12.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$12.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure15.1Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$15.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure14.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$14.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure21.1Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$21.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure13.0Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$13.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure14.4Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$14.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure16.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$16.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure16.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$16.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure15.0Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$15.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure18.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$18.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure25.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$25.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure29.5Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$29.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Operating income$m(43.1)Operating income, Q3 FY2023, three months to 2023-09-30−$43.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure(76.8)Operating income, Q4 FY2023, three months to 2023-12-31−$76.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure(46.1)Operating income, Q1 FY2024, three months to 2024-03-31−$46.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure(49.2)Operating income, Q2 FY2024, three months to 2024-06-30−$49.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure(62.3)Operating income, Q3 FY2024, three months to 2024-09-30−$62.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(19.2)Operating income, Q4 FY2024, three months to 2024-12-31−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(16.9)Operating income, Q1 FY2025, three months to 2025-03-31−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(15.1)Operating income, Q2 FY2025, three months to 2025-06-30−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(11.0)Operating income, Q3 FY2025, three months to 2025-09-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(12.6)Operating income, Q4 FY2025, three months to 2025-12-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(43.1)Operating income, Q1 FY2026, three months to 2026-03-31−$43.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(45.8)Operating income, Q2 FY2026, three months to 2026-06-30−$45.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Net income$m(39.4)Net income, Q3 FY2023, three months to 2023-09-30−$39.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure(73.7)Net income, Q4 FY2023, three months to 2023-12-31−$73.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure(43.5)Net income, Q1 FY2024, three months to 2024-03-31−$43.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(47.2)Net income, Q2 FY2024, three months to 2024-06-30−$47.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(60.7)Net income, Q3 FY2024, three months to 2024-09-30−$60.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(18.4)Net income, Q4 FY2024, three months to 2024-12-31−$18.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Net income, Q1 FY2025, three months to 2025-03-31−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(14.7)Net income, Q2 FY2025, three months to 2025-06-30−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(10.5)Net income, Q3 FY2025, three months to 2025-09-30−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure(11.1)Net income, Q4 FY2025, three months to 2025-12-31−$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(41.4)Net income, Q1 FY2026, three months to 2026-03-31−$41.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(44.4)Net income, Q2 FY2026, three months to 2026-06-30−$44.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Diluted EPS$ per share(0.36)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figurenot reported(0.38)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure(0.40)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure(0.51)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figurenot reported(0.14)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(0.06)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Basic EPS$ per share(0.36)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figurenot reported(0.38)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure(0.40)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure(0.51)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figurenot reported(0.14)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure(0.06)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figurenot reported(0.13)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure

Balance sheet

Cash and equivalents$160.1m, Q2 FY2026
Shareholders' equity$181.1m, Q2 FY2026
Invivyd, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m182Cash and equivalents, Q3 FY2023, at 2023-09-30$181.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure201Cash and equivalents, FY2023, at 2023-12-31$200.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0000950170-25-042332.Report this figure189Cash and equivalents, Q1 FY2024, at 2024-03-31$189.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure148Cash and equivalents, Q2 FY2024, at 2024-06-30$147.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure107Cash and equivalents, Q3 FY2024, at 2024-09-30$106.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure69.3Cash and equivalents, FY2024, at 2024-12-31$69.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure48.1Cash and equivalents, Q1 FY2025, at 2025-03-31$48.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure34.9Cash and equivalents, Q2 FY2025, at 2025-06-30$34.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure85.0Cash and equivalents, Q3 FY2025, at 2025-09-30$85.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure227Cash and equivalents, FY2025, at 2025-12-31$226.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure184Cash and equivalents, Q1 FY2026, at 2026-03-31$184.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure160Cash and equivalents, Q2 FY2026, at 2026-06-30$160.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Current assets$m270Current assets, Q3 FY2023, at 2023-09-30$270.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure225Current assets, FY2023, at 2023-12-31$224.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042332.Report this figure210Current assets, Q1 FY2024, at 2024-03-31$209.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure173Current assets, Q2 FY2024, at 2024-06-30$173.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure151Current assets, Q3 FY2024, at 2024-09-30$151.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure101Current assets, FY2024, at 2024-12-31$100.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure75.8Current assets, Q1 FY2025, at 2025-03-31$75.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure59.3Current assets, Q2 FY2025, at 2025-06-30$59.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure110Current assets, Q3 FY2025, at 2025-09-30$109.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure247Current assets, FY2025, at 2025-12-31$247.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure205Current assets, Q1 FY2026, at 2026-03-31$204.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure182Current assets, Q2 FY2026, at 2026-06-30$182.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Total assets$m275Total assets, Q3 FY2023, at 2023-09-30$274.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure229Total assets, FY2023, at 2023-12-31$229.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0000950170-25-042332.Report this figure215Total assets, Q1 FY2024, at 2024-03-31$215.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure177Total assets, Q2 FY2024, at 2024-06-30$177.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure162Total assets, Q3 FY2024, at 2024-09-30$161.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure130Total assets, FY2024, at 2024-12-31$129.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure104Total assets, Q1 FY2025, at 2025-03-31$103.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure89.1Total assets, Q2 FY2025, at 2025-06-30$89.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure139Total assets, Q3 FY2025, at 2025-09-30$139.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure277Total assets, FY2025, at 2025-12-31$276.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure242Total assets, Q1 FY2026, at 2026-03-31$241.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure219Total assets, Q2 FY2026, at 2026-06-30$218.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Current liabilities$m26.8Current liabilities, Q3 FY2023, at 2023-09-30$26.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure50.3Current liabilities, FY2023, at 2023-12-31$50.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042332.Report this figure36.3Current liabilities, Q1 FY2024, at 2024-03-31$36.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure36.7Current liabilities, Q2 FY2024, at 2024-06-30$36.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure78.5Current liabilities, Q3 FY2024, at 2024-09-30$78.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure62.0Current liabilities, FY2024, at 2024-12-31$62.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure49.6Current liabilities, Q1 FY2025, at 2025-03-31$49.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure44.5Current liabilities, Q2 FY2025, at 2025-06-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure44.5Current liabilities, Q3 FY2025, at 2025-09-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure34.2Current liabilities, FY2025, at 2025-12-31$34.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure31.7Current liabilities, Q1 FY2026, at 2026-03-31$31.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure31.0Current liabilities, Q2 FY2026, at 2026-06-30$31.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Total liabilities$m28.4Total liabilities, Q3 FY2023, at 2023-09-30$28.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure51.7Total liabilities, FY2023, at 2023-12-31$51.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0000950170-25-042332.Report this figure37.0Total liabilities, Q1 FY2024, at 2024-03-31$37.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure36.7Total liabilities, Q2 FY2024, at 2024-06-30$36.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure78.8Total liabilities, Q3 FY2024, at 2024-09-30$78.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure62.0Total liabilities, FY2024, at 2024-12-31$62.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure49.6Total liabilities, Q1 FY2025, at 2025-03-31$49.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure46.3Total liabilities, Q2 FY2025, at 2025-06-30$46.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure46.1Total liabilities, Q3 FY2025, at 2025-09-30$46.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure35.3Total liabilities, FY2025, at 2025-12-31$35.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure38.7Total liabilities, Q1 FY2026, at 2026-03-31$38.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure37.8Total liabilities, Q2 FY2026, at 2026-06-30$37.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure
Shareholders' equity$m246Shareholders' equity, Q3 FY2023, at 2023-09-30$246.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure177Shareholders' equity, FY2023, at 2023-12-31$177.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-092547.Report this figure178Shareholders' equity, Q1 FY2024, at 2024-03-31$178.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure141Shareholders' equity, Q2 FY2024, at 2024-06-30$140.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure83.2Shareholders' equity, Q3 FY2024, at 2024-09-30$83.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure67.5Shareholders' equity, FY2024, at 2024-12-31$67.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure54.1Shareholders' equity, Q1 FY2025, at 2025-03-31$54.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure42.8Shareholders' equity, Q2 FY2025, at 2025-06-30$42.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure93.1Shareholders' equity, Q3 FY2025, at 2025-09-30$93.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure242Shareholders' equity, FY2025, at 2025-12-31$241.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure203Shareholders' equity, Q1 FY2026, at 2026-03-31$203.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure181Shareholders' equity, Q2 FY2026, at 2026-06-30$181.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure

Cash flow

Operating cash flow−$43.0m, Q2 FY2026
Capital expenditure$510.0k, Q2 FY2026
Share repurchases$0, Q4 FY2024
Invivyd, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(35.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$35.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-126735. Derived: 9-month figure less the 6-month figure.Report this figure(59.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$59.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure(50.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$50.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure(41.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$41.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-109029. Derived: 6-month figure less the 3-month figure.Report this figure(41.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$41.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268076. Derived: 9-month figure less the 6-month figure.Report this figure(37.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$37.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(21.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(13.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349215. Derived: 6-month figure less the 3-month figure.Report this figure(8.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268076. Derived: 9-month figure less the 6-month figure.Report this figure(15.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure(41.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$41.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure(43.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$43.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349215. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-126735. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-109029. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268076. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$144.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349215. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268076. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092547. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$726.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure0.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$510.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349215. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-14, accession 0000950170-24-126735. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-14, accession 0000950170-24-126735. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-20, accession 0000950170-25-042332. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)320.44m, Q2 FY2026
Invivyd, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares108Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30108,420,674 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062043.Report this figure109Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31108,785,519 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-057017.Report this figure109Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30109,450,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-096674.Report this figure110Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30109,754,812 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-126735.Report this figure116Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31115,618,209 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-071974.Report this figure119Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30119,362,670 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-109029.Report this figure119Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30119,495,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure120Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31119,883,479 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure120Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30120,016,132 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure170Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30170,169,865 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268076.Report this figure310Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31309,670,101 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222779.Report this figure320Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30320,435,078 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure

Shares outstanding: 294.76mShares outstanding, period not labelled, at 2026-07-30294,758,746 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349215.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.